spacer
spacer

PDBsum entry 2gpp

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transcription PDB id
2gpp

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
225 a.a. *
11 a.a. *
13 a.a. *
Ligands
1BA
Waters ×25
* Residue conservation analysis
PDB id:
2gpp
Name: Transcription
Title: Estrogen related receptor-gamma ligand binding domain complexed with a rip140 peptide and synthetic ligand gsk4716
Structure: Estrogen-related receptor gamma. Chain: a, b. Fragment: residues (229-458). Synonym: estrogen receptor-related protein 3, err gamma-2. Engineered: yes. Nuclear receptor-interacting protein 1. Chain: c, d. Fragment: residues (366-390). Synonym: nuclear factor rip140, receptor-interacting protein 140.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: esrrg. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes. Other_details: chemically synthesized. Occurs naturally in humans.
Biol. unit: Tetramer (from PQS)
Resolution:
2.60Å     R-factor:   0.233     R-free:   0.257
Authors: L.Wang,W.J.Zuercher,T.G.Consler,M.H.Lambert,A.B.Miller,L.A.Osband- Miller,D.D.Mckee,T.M.Willson,R.T.Nolte
Key ref:
L.Wang et al. (2006). X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation. J Biol Chem, 281, 37773-37781. PubMed id: 16990259 DOI: 10.1074/jbc.M608410200
Date:
18-Apr-06     Release date:   26-Sep-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P62508  (ERR3_HUMAN) -  Estrogen-related receptor gamma from Homo sapiens
Seq:
Struc:
458 a.a.
225 a.a.
Protein chain
Pfam   ArchSchema ?
P48552  (NRIP1_HUMAN) -  Nuclear receptor-interacting protein 1 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1158 a.a.
11 a.a.
Protein chain
Pfam   ArchSchema ?
P48552  (NRIP1_HUMAN) -  Nuclear receptor-interacting protein 1 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1158 a.a.
13 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: Chains A, B, C, D: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1074/jbc.M608410200 J Biol Chem 281:37773-37781 (2006)
PubMed id: 16990259  
 
 
X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.
L.Wang, W.J.Zuercher, T.G.Consler, M.H.Lambert, A.B.Miller, L.A.Orband-Miller, D.D.McKee, T.M.Willson, R.T.Nolte.
 
  ABSTRACT  
 
X-ray crystal structures of the ligand binding domain (LBD) of the estrogen-related receptor-gamma (ERRgamma) were determined that describe this receptor in three distinct states: unliganded, inverse agonist bound, and agonist bound. Two structures were solved for the unliganded state, the ERRgamma LBD alone, and in complex with a coregulator peptide representing a portion of receptor interacting protein 140 (RIP140). No significant differences were seen between these structures that both exhibited the conformation of ERRgamma seen in studies with other coactivators. Two structures were obtained describing the inverse agonist-bound state, the ERRgamma LBD with 4-hydroxytamoxifen (4-OHT), and the ERRgamma LBD with 4-OHT and a peptide representing a portion of the silencing mediator of retinoid and thyroid hormone action protein (SMRT). The 4-OHT structure was similar to other reported inverse agonist bound structures, showing reorientation of phenylalanine 435 and a displacement of the AF-2 helix relative to the unliganded structures with little other rearrangement occurring. No significant changes to the LBD appear to be induced by peptide binding with the addition of the SMRT peptide to the ERRgamma plus 4-OHT complex. The observed agonist-bound state contains the ERRgamma LBD, a ligand (GSK4716), and the RIP140 peptide and reveals an unexpected rearrangement of the phenol-binding residues. Thermal stability studies show that agonist binding leads to global stabilization of the ligand binding domain. In contrast to the conventional mechanism of nuclear receptor ligand activation, activation of ERRgamma by GSK4716 does not appear to involve a major rearrangement or significant stabilization of the C-terminal helix.
 
  Selected figure(s)  
 
Figure 4.
FIGURE 4. ERR ·4-OHT·SMRT complex. The tetrameric assembly containing four of the six molecules in the asymmetric unit is shown. A ribbon representation of the ERR monomers is shown with each monomer shown with a distinct color: yellow, molecule A; magenta, molecule B; blue, molecule C; and green, molecule D. The ligand is depicted as a stick figure with orange carbon atoms. Residues 319-330 of the SMRT peptide are depicted as cyan ribbons with peptide chain G binding ERR chain A and peptide chain H binding ERR chain B. The remaining two molecules in the asymmetric unit form a similar tetramer with symmetrically related copies of themselves around a crystallographic 2-fold axis.
Figure 7.
FIGURE 7. Plot of ligand interactions in the ERR ·GSK4716·RIP140 complex. Hydrogen bonds involving the ligand are shown in red, with distances denoted in angstroms. The ligand hydrogen bonds directly to two residues, the side chain of Asp-328 and the back bone carbonyl of Tyr-327. Indirect hydrogen bonds to the ligand exist through two waters to the side chain of Arg-316 and the main chain of Leu-309. Residues denoted in blue are >4.0 Å from the ligand.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2006, 281, 37773-37781) copyright 2006.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
23192231 G.Deblois, and V.Giguère (2013).
Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.
  Nat Rev Cancer, 13, 27-36.  
20135221 M.Koh, and S.B.Park (2011).
Computer-aided design and synthesis of tetra-aryl-substituted alkenes and their bioevaluation as a selective modulator of estrogen-related receptor γ.
  Mol Divers, 15, 69-81.  
21138943 R.Berry, L.Harewood, L.Pei, M.Fisher, D.Brownstein, A.Ross, W.A.Alaynick, J.Moss, N.D.Hastie, P.Hohenstein, J.A.Davies, R.M.Evans, and D.R.Fitzpatrick (2011).
Esrrg functions in early branch generation of the ureteric bud and is essential for normal development of the renal papilla.
  Hum Mol Genet, 20, 917-926.  
20543827 A.le Maire, C.Teyssier, C.Erb, M.Grimaldi, S.Alvarez, A.R.de Lera, P.Balaguer, H.Gronemeyer, C.A.Royer, P.Germain, and W.Bourguet (2010).
A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.
  Nat Struct Mol Biol, 17, 801-807.
PDB codes: 3kmr 3kmz
20063036 A.le Maire, W.Bourguet, and P.Balaguer (2010).
A structural view of nuclear hormone receptor: endocrine disruptor interactions.
  Cell Mol Life Sci, 67, 1219-1237.
PDB code: 3kwy
20581824 C.A.Phelan, R.T.Gampe, M.H.Lambert, D.J.Parks, V.Montana, J.Bynum, T.M.Broderick, X.Hu, S.P.Williams, R.T.Nolte, and M.A.Lazar (2010).
Structure of Rev-erbalpha bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interaction.
  Nat Struct Mol Biol, 17, 808-814.
PDB code: 3n00
20541699 R.J.Andersen, N.R.Mawji, J.Wang, G.Wang, S.Haile, J.K.Myung, K.Watt, T.Tam, Y.C.Yang, C.A.Bañuelos, D.E.Williams, I.J.McEwan, Y.Wang, and M.D.Sadar (2010).
Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor.
  Cancer Cell, 17, 535-546.  
20418374 S.M.Rangwala, X.Wang, J.A.Calvo, L.Lindsley, Y.Zhang, G.Deyneko, V.Beaulieu, J.Gao, G.Turner, and J.Markovits (2010).
Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity.
  J Biol Chem, 285, 22619-22629.  
20372994 S.Mukherjee, and S.Mani (2010).
Orphan nuclear receptors as targets for drug development.
  Pharm Res, 27, 1439-1468.  
20542892 X.Liu, A.Matsushima, H.Okada, and Y.Shimohigashi (2010).
Distinction of the binding modes for human nuclear receptor ERRgamma between bisphenol A and 4-hydroxytamoxifen.
  J Biochem, 148, 247-254.  
18509053 A.Ao, H.Wang, S.Kamarajugadda, and J.Lu (2008).
Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors.
  Proc Natl Acad Sci U S A, 105, 7821-7826.  
  18197296 H.Okada, T.Tokunaga, X.Liu, S.Takayanagi, A.Matsushima, and Y.Shimohigashi (2008).
Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma.
  Environ Health Perspect, 116, 32-38.  
18174917 A.M.Tremblay, and V.Giguère (2007).
The NR3B subgroup: an ovERRview.
  Nucl Recept Signal, 5, e009.  
17906643 A.R.de Lera, W.Bourguet, L.Altucci, and H.Gronemeyer (2007).
Design of selective nuclear receptor modulators: RAR and RXR as a case study.
  Nat Rev Drug Discov, 6, 811-820.  
18052088 S.M.Hyatt, E.L.Lockamy, R.A.Stein, D.P.McDonnell, A.B.Miller, L.A.Orband-Miller, T.M.Willson, and W.J.Zuercher (2007).
On the intractability of estrogen-related receptor alpha as a target for activation by small molecules.
  J Med Chem, 50, 6722-6724.  
18037887 S.Raghuram, K.R.Stayrook, P.Huang, P.M.Rogers, A.K.Nosie, D.B.McClure, L.L.Burris, S.Khorasanizadeh, T.P.Burris, and F.Rastinejad (2007).
Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta.
  Nat Struct Mol Biol, 14, 1207-1213.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer